ARTICLE | Company News
Immunovaccine, IRX deal
October 11, 2010 7:00 AM UTC
The companies will evaluate the combination of IRX Therapeutics' IRX-2 with ImmunoVaccine's DepoVax technology as a potential therapeutic cancer vaccine. IRX-2, an immune system stimulant comprised ...